Non-steroidal anti-inflammatory drugs in football – a “Keeping SCORE” approach to judicious use

References

• Conaghan PG. 2012. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 32(6):1491–1502. doi:10.1007/s00296-011-2263-6.
   PubMed Web of Science ®Google Scholar
• Day RO, Graham GG. 2013. Republished research: non-steroidal anti-inflammatory drugs (NSAIDs). Br J Sports Med. 47(17):1127. doi:10.1136/bjsports-2013-f3195rep.
   PubMed Web of Science ®Google Scholar
• Derry S, Moore RA, Gaskell H, McIntyre M, Wiffen PJ. 2015. Topical NSAIDs for acute musculoskeletal pain in adults. The Cochrane Database Syst Rev. 2015(6):Cd007402. doi:10.1002/14651858.CD007402.pub3.
   PubMedGoogle Scholar
• Dijkstra HP, Pollock N, Chakraverty R, Alonso JM. 2014. Managing the health of the elite athlete: a new integrated performance health management and coaching model. Br J Sports Med. 48(7):523. doi:10.1136/bjsports-2013-093222.
   PubMed Web of Science ®Google Scholar
• Enthoven WT, Roelofs PD, Deyo RA, van Tulder MW, Koes BW, van Tulder MW. Non-steroidal anti-inflammatory drugs for chronic low back pain. The Cochrane Database Syst Rev. 2016(28):Cd012087. doi:10.1002/14651858.CD012087.
   Google Scholar
• Fernandes GS, Parekh SM, Moses J, Fuller CW, Scammell B, Batt ME, Zhang W, Doherty M. 2019. Depressive symptoms and the general health of retired professional footballers compared with the general population in the UK: a case–control study. BMJ Open. 9(9):e030056. doi:10.1136/bmjopen-2019-030056.
   PubMed Web of Science ®Google Scholar
• Gorski T, Cadore EL, Pinto SS, da Silva EM, Correa CS, Beltrami FG, et al. 2011. Use of NSAIDs in triathletes: prevalence, level of awareness and reasons for use. Br J Sports Med. 45(2):85–90. doi:10.1136/bjsm.2009.062166.
   PubMed Web of Science ®Google Scholar
• Harle CA, Danielson EC, Derman W, Stuart M, Dvorak J, Smith L, et al. 2018. Analgesic management of pain in elite athletes: a systematic review. Clin J Sport Med. 28(5):417–426. doi:10.1097/JSM.0000000000000604.
   PubMed Web of Science ®Google Scholar
• Hörl WH. 2010. Nonsteroidal anti-inflammatory drugs and the kidney. Pharm (Basel). 3(7):2291–2321. doi:10.3390/ph3072291.
   Google Scholar
• Hosokawa Y, Grundstein AJ, Casa DJ. 2018. Extreme heat considerations in international football venues: the utility of climatologic data in decision making. J Athl Train. 53(9):860–865. doi:10.4085/1062-6050-361-17.
   PubMed Web of Science ®Google Scholar
• Küster M, Renner B, Oppel P, Niederweis U, Brune K. 2013. Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study. BMJ Open. 3(4):e002090. doi:10.1136/bmjopen-2012-002090.
   PubMed Web of Science ®Google Scholar
• Lilly KA. 2010. NSAID, coxibs, and the gastrointestinal tract. Curr Sports Med Rep. 9(2):103–105. doi:10.1249/JSR.0b013e3181d405a9.
   PubMed Web of Science ®Google Scholar
• Lipman GS, Shea K, Christensen M, Phillips C, Burns P, Higbee R, et al. 2017. Ibuprofen versus placebo effect on acute kidney injury in ultramarathons: a randomised controlled trial. Emergency Med J. 34(10):637. doi:10.1136/emermed-2016-206353.
   PubMed Web of Science ®Google Scholar
• Machado GC, Abdel-Shaheed C, Underwood M, Day RO. 2021. Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain. BMJ. 372(n104):n104. doi:10.1136/bmj.n104.
   PubMedGoogle Scholar
• Mackey AL, Mikkelsen UR, Magnusson SP, Kjaer M. 2012. Rehabilitation of muscle after injury – the role of anti-inflammatory drugs. Scand J Med Sci Sports. 22(4):e8–14. doi:10.1111/j.1600-0838.2012.01463.x.
   PubMed Web of Science ®Google Scholar
• Magra M, Maffulli N. 2006. Nonsteroidal antiinflammatory drugs in tendinopathy: friend or foe. Clin J Sport Med. 16(1):1–3. doi:10.1097/01.jsm.0000194764.27819.5d.
   PubMed Web of Science ®Google Scholar
• Mahler N. 2001. Misuse of drugs in recreational sports. Ther Umsch. 58(4):226–231. doi:10.1024/0040-5930.58.4.226.
   PubMedGoogle Scholar
• Maxwell SR. 2016. Rational prescribing: the principles of drug selection. Clin Med (Northfield Il). 16(5):459–464. doi:10.7861/clinmedicine.16-5-459.
   PubMed Web of Science ®Google Scholar
• Mehallo CJ, Drezner JA, Bytomski JR. 2006. Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries. Clin J Sport Med. 16(2):170–174. doi:10.1097/00042752-200603000-00015.
   PubMed Web of Science ®Google Scholar
• Mercer A, Hillis W. 2014. Medication and supplement use in Scottish professional football. Scott Med J. 59(3):E30.
   PubMed Web of Science ®Google Scholar
• Mkumbuzi NS, Dlamini SB, Chibhabha F, Govere FM. 2021. Injury, illness, and medication use surveillance during the 2020 COSAFA women’s championship: a prospective cohort study of football players from southern africa. Sci Med Football. 1–7. doi:10.1080/24733938.2021.1971745.
   Google Scholar
• Oester C, Weber A, Vaso M. 2019. Retrospective study of the use of medication and supplements during the 2018 FIFA World Cup Russia. BMJ Open Sport Exercise Med. 5(1):e000609. doi:10.1136/bmjsem-2019-000609.
   PubMedGoogle Scholar
• Osterberg L, Blaschke T. 2005. Adherence to medication. N Engl J Med. 353(5):487–497. doi:10.1056/NEJMra050100.
   PubMed Web of Science ®Google Scholar
• Pawlosky N. 2013. Cardiovascular risk: are all NSAIDs alike? Can Pharm J : CPJ. 146(2):80–83. doi:10.1177/1715163513481569.
   Google Scholar
• Prisk V, Huard J. 2003. Muscle injuries and repair: the role of prostaglandins and inflammation. Histol Histopathol. 18(4):1243–1256. doi:10.14670/HH-18.1243.
   PubMed Web of Science ®Google Scholar
• Read D, Smith ACT, Skinner J. 2022. Theorising painkiller (mis)use in football using Bourdieu’s practice theory and physical capital. Int Rev Sociol Sport. doi:10.126902221082483.
   Web of Science ®Google Scholar
• Rosenbloom CJ, Morley FL, Ahmed I, Cox AR. 2020. Oral non-steroidal anti-inflammatory drug use in recreational runners participating in Parkrun UK: prevalence of use and awareness of risk. Int J Pharm Pract. 28(6):561–568. doi:10.1111/ijpp.12646.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Sørensen HT, Pedersen L. 2018. Diclofenac use and cardiovascular risks: series of nationwide cohort studies. BMJ. 362:k3426. doi:10.1136/bmj.k3426.
   PubMed Web of Science ®Google Scholar
• Taioli E. 2007. Use of permitted drugs in Italian professional soccer players. Br J Sports Med. 41(7):439. doi:10.1136/bjsm.2006.034405.
   PubMed Web of Science ®Google Scholar
• Thuyne WV, Delbeke FT. 2008. Declared use of medication in sports. Clin J Sport Med. 18(2):143–147. doi:10.1097/JSM.0b013e318163f220.
   PubMed Web of Science ®Google Scholar
• Trinks S, Scheiff AB, Knipp M, Gotzmann A. 2021. Declaration of analgesics on doping control forms in german football leagues during five seasons. Deutsche Zeitschrift F¸r Sportmedizin. 72(No. 2):68–74. doi:10.5960/dzsm.2020.474.
   Google Scholar
• Tscholl PM, Dvorak J. 2012. Abuse of medication during international football competition in 2010 – lesson not learned. Br J Sports Med. 46(16):1140–1141. doi:10.1136/bjsports-2011-090806.
   PubMed Web of Science ®Google Scholar
• Tscholl Ph M, Gard S, Schindler M. 2017. A sensible approach to the use of NSAIDs in sports medicine. Schweiz Z Med Traumatol. 65:15–20.
   Google Scholar
• Tscholl PM, Vaso M, Weber A, Dvorak J. 2015. High prevalence of medication use in professional football tournaments including the World Cups between 2002 and 2014: a narrative review with a focus on NSAIDs. Br J Sports Med. 49(9):580–582. doi:10.1136/bjsports-2015-094784.
   PubMed Web of Science ®Google Scholar
• Urso ML. 2013. Anti-inflammatory interventions and skeletal muscle injury: benefit or detriment? J Appl Physiol. 115(6):920–928. doi:10.1152/japplphysiol.00036.2013.
   PubMed Web of Science ®Google Scholar
• van der Gaag WH, Roelofs PD, Enthoven WT, van Tulder MW, Koes BW. 2020. Non-steroidal anti-inflammatory drugs for acute low back pain. The Cochrane Database Syst Rev. 4(4):Cd013581. doi:10.1002/14651858.CD013581.
   PubMedGoogle Scholar
• Vaso M, Weber A, Tscholl PM, Junge A, Dvorak J. 2015. Use and abuse of medication during 2014 FIFA World Cup Brazil: a retrospective survey. BMJ Open. 5(9):e007608. doi:10.1136/bmjopen-2015-007608.
   PubMed Web of Science ®Google Scholar
• Weir MR. 2002. Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med. 69(1):Si53–8. doi:10.3949/ccjm.69.Suppl_1.SI53.
   PubMedGoogle Scholar
• WHARAM PC, SPEEDY DB, NOAKES TD, THOMPSON JMD, REID SA, HOLTZHAUSEN L-M. 2006. NSAID use increases the risk of developing hyponatremia during an ironman triathlon. Med Sci Sports Exercise. 38(4):618–622. doi:10.1249/01.mss.0000210209.40694.09.
   PubMed Web of Science ®Google Scholar
• Wheatley BM, Nappo KE, Christensen DL, Holman AM, Brooks DI, Potter BK. 2019. Effect of NSAIDs on bone healing rates: a meta-analysis. JAAOS - J Am Acad Orthopaedic Surgeons. 27(7):e330–6. doi:10.5435/JAAOS-D-17-00727.
   PubMed Web of Science ®Google Scholar
• The yellow card scheme: guidance for healthcare professionals, patients and the public. [ Available from: https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals.
   Google Scholar